Well-Healthcare Technology has recently completed tens of millions of yuan in Series A financing round, led by SinoWisdom and joined by Thunderstorm VC, with its existing investor SDIC Venture Capital continuing to increase its stake.
Lianchuan Bio recently announced the completion of a total of 115 million yuan in a Series B financing round.
This round of financing was led by Hangzhou Heda Bio-Pharmaceutical Venture Partnership, with participation from Beijing Junchuan Capital, Hangzhou Taimeng Investment, as well as existing investors Sinowisdom, ZSVC and Crestvalue.
Xinyi Information Technology has garnered nearly 200 million yuan in a Series A+ round of financing. This round was led by CTC Capital Partners, with participation from SinoWisdom and three existing investors Frees Fund, Oriental Jiafu Asset Management and Septwolves.